Regulation of Complement and Contact System Activation via C1 Inhibitor Potentiation and Factor XIIa Activity Modulation by Sulfated Glycans - Structure-Activity Relationships

about

Pathogenesis of Drug Induced Non-Allergic Angioedema: A Review of Unusual Etiologies Heparin Mimetics: Their Therapeutic Potential.

P2860

Q42649822-428B706B-6804-41A0-BAAE-F4CADB626270 Q47159791-E3C25588-5F88-4C2D-A246-4CC43931D5E2

P2860

Regulation of Complement and Contact System Activation via C1 Inhibitor Potentiation and Factor XIIa Activity Modulation by Sulfated Glycans - Structure-Activity Relationships

Item

http://www.wikidata.org/entity/Q36175011

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Regulation of Complement and C ...... ructure-Activity Relationships

@ast

Regulation of Complement and C ...... ructure-Activity Relationships

@en

type

Item

label

Regulation of Complement and C ...... ructure-Activity Relationships

@ast

Regulation of Complement and C ...... ructure-Activity Relationships

@en

prefLabel

Regulation of Complement and C ...... ructure-Activity Relationships

@ast

Regulation of Complement and C ...... ructure-Activity Relationships

@en

P1476

Regulation of Complement and C ...... ructure-Activity Relationships

@en

P2093

Ann-Kathrin Schoenfeld

http://www.w3.org/2001/XMLSchema#string

Eric Lahrsen

http://www.w3.org/2001/XMLSchema#string

Susanne Alban

http://www.w3.org/2001/XMLSchema#string

P2860

Proteolytic activities of two types of mannose-binding lectin-associated serine protease

Contaminated heparin associated with adverse clinical events and activation of the contact system

Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III

C1 inhibitor serpin domain structure reveals the likely mechanism of heparin potentiation and conformational disease

BIOLOGICAL ACTIVITIES OF C1 INHIBITOR

Identification of a putative binding site for negatively charged surfaces in the fibronectin type II domain of human factor XII--an immunochemical and homology modeling approach.

Interaction of fucoidan with the proteins of the complement classical pathway.

Elucidation of the substrate specificity of the MASP-2 protease of the lectin complement pathway and identification of the enzyme as a major physiological target of the serpin, C1-inhibitor.

A review of the reported defects in the human C1 esterase inhibitor gene producing hereditary angioedema including four new mutations.

Complement C1 esterase inhibitor levels linked to infections and contaminated heparin-associated adverse events

P304

e0165493

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0165493

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27783665

http://www.w3.org/2001/XMLSchema#string

P932

5082678

http://www.w3.org/2001/XMLSchema#string

Regulation of Complement and Contact System Activation via C1 Inhibitor Potentiation and Factor XIIa Activity Modulation by Sulfated Glycans - Structure-Activity Relationships

about

P2860

P2860

Regulation of Complement and Contact System Activation via C1 Inhibitor Potentiation and Factor XIIa Activity Modulation by Sulfated Glycans - Structure-Activity Relationships

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932